These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8840099)

  • 1. Role of albumin glycation on the erythrocyte aggregation: an in vitro study.
    Candiloros H; Muller S; Ziegler O; Donner M; Drouin P
    Diabet Med; 1996 Jul; 13(7):646-50. PubMed ID: 8840099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural modifications of human albumin in diabetes.
    Guerin-Dubourg A; Catan A; Bourdon E; Rondeau P
    Diabetes Metab; 2012 Apr; 38(2):171-8. PubMed ID: 22349032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of advanced glycation end-products with glutathione status.
    Sahin E; Göçmen AY; Koçak H; Tuncer M; Gümüslü S
    Ann Clin Biochem; 2008 Jul; 45(Pt 4):369-74. PubMed ID: 18583621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorometric and mass spectrometric analysis of nonenzymatic glycosylated albumin.
    Zoellner H; Hou JY; Hochgrebe T; Poljak A; Duncan MW; Golding J; Henderson T; Lynch G
    Biochem Biophys Res Commun; 2001 Jun; 284(1):83-9. PubMed ID: 11374874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catabolism of unglycated and naturally glycated forms of rabbit fibrinogen: their interaction with the healthy and deendothelialized aorta wall in normal and diabetic rabbits.
    Hatton MW; Southward S; Ross-Ouellet B; Richardson M; Winocour PD
    J Lab Clin Med; 1993 Apr; 121(4):588-97. PubMed ID: 8454941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycation of interferon-beta-1b and human serum albumin in a lyophilized glucose formulation. Part III: application of proteomic analysis to the manufacture of biological drugs.
    Zheng X; Wu SL; Hancock WS
    Int J Pharm; 2006 Sep; 322(1-2):136-45. PubMed ID: 16920285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential recognition of Amadori-rich lysine residues by serum antibodies in diabetes mellitus: role of protein glycation in the disease process.
    Ansari NA; Moinuddin ; Alam K; Ali A
    Hum Immunol; 2009 Jun; 70(6):417-24. PubMed ID: 19332092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of zinc along with ascorbic acid and folic acid during long-term in vitro albumin glycation.
    Tupe RS; Agte VV
    Br J Nutr; 2010 Feb; 103(3):370-7. PubMed ID: 19849871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel advanced glycation index and its association with diabetes and microangiopathy.
    Sampathkumar R; Balasubramanyam M; Rema M; Premanand C; Mohan V
    Metabolism; 2005 Aug; 54(8):1002-7. PubMed ID: 16092048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of advanced glycation end products for biochemical studies: side chain modifications and fluorescence characteristics.
    Schmitt A; Schmitt J; Münch G; Gasic-Milencovic J
    Anal Biochem; 2005 Mar; 338(2):201-15. PubMed ID: 15745740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-Carnitine inhibits protein glycation in vitro and in vivo: evidence for a role in diabetic management.
    Rajasekar P; Anuradha CV
    Acta Diabetol; 2007 Jun; 44(2):83-90. PubMed ID: 17530472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma glycooxidation protein products in type 2 diabetic patients with nephropathy.
    Piwowar A; Knapik-Kordecka M; Szczecińska J; Warwas M
    Diabetes Metab Res Rev; 2008 Oct; 24(7):549-53. PubMed ID: 18613218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunochemical quantification of crossline as a fluorescent advanced glycation endproduct in erythrocyte membrane proteins from diabetic patients with or without retinopathy.
    Yamaguchi M; Nakamura N; Nakano K; Kitagawa Y; Shigeta H; Hasegawa G; Ienaga K; Nakamura K; Nakazawa Y; Fukui I; Obayashi H; Kondo M
    Diabet Med; 1998 Jun; 15(6):458-62. PubMed ID: 9632118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-molecular but not high-molecular advanced glycation end products (AGEs) are removed by high-flux dialysis.
    Gerdemann A; Lemke HD; Nothdurft A; Heidland A; Münch G; Bahner U; Schinzel R
    Clin Nephrol; 2000 Oct; 54(4):276-83. PubMed ID: 11076103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pigment epithelium-derived factor (PEDF) prevents platelet activation and aggregation in diabetic rats by blocking deleterious effects of advanced glycation end products (AGEs).
    Yamagishi S; Matsui T; Takenaka K; Nakamura K; Takeuchi M; Inoue H
    Diabetes Metab Res Rev; 2009 Mar; 25(3):266-71. PubMed ID: 19165765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of mass spectrometry in the study of non-enzymatic protein glycation in diabetes: an update.
    Lapolla A; Fedele D; Seraglia R; Traldi P
    Mass Spectrom Rev; 2006; 25(5):775-97. PubMed ID: 16625652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ilex paraguariensis extracts inhibit AGE formation more efficiently than green tea.
    Lunceford N; Gugliucci A
    Fitoterapia; 2005 Jul; 76(5):419-27. PubMed ID: 15894431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The structure of the sugar residue in glycated human serum albumin and its molecular recognition by phenylboronate.
    Rohovec J; Maschmeyer T; Aime S; Peters JA
    Chemistry; 2003 May; 9(10):2193-9. PubMed ID: 12772293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red blood cell aggregation in diabetes mellitus.
    Le Devehat C; Vimeux M; Bondoux G; Khodabandehlou T
    Int Angiol; 1990; 9(1):11-5. PubMed ID: 2212794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alginate as an antiglycating agent for human serum albumin.
    Sattarahmady N; Khodagholi F; Moosavi-Movahedi AA; Heli H; Hakimelahi GH
    Int J Biol Macromol; 2007 Jul; 41(2):180-4. PubMed ID: 17350677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.